COMPANY PROFILE

XACT-logo-blk-bg-v2

XACT Robotics is advancing the field of radiology, pioneering the first hands-free robotic system combining image-based planning and navigation with instrument insertion and steering capabilities, to democratize percutaneous interventional procedures.

MANAGEMENT

Harel Gadot

Harel Gadot, Executive Chairman & President

Harel is a seasoned executive and entrepreneur in the healthcare space, with an extensive and proven track record. Harel brings over 19 years of experience in leadership positions in the corporate world as well as the start-up sector, including the United States, Europe, and Israel. Harel founded MEDX Ventures Group in 2010, a unique investment and management firm, and serves as its Company Group Chairman. 

Harel founded XACT Robotics in 2013 and serves as its Executive Chairman and President. He also serves as the CEO, President & Chairman of Microbot Medical Inc. (Nasdaq: MBOT), where he co-founded the company in 2011 and led it through its successful listing on NASDAQ in 2016. In addition, Harel is the founder and Chairman of MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures, and Sheba Medical Center. Until 2013, Harel served on the board of directors at ConTIPI Ltd., and played an instrumental role in its commercial efforts, resulting in its acquisition by Kimberly Clark Corporation. 

Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville, NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, the Middle East, and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches (both from internal R&D and M&A). Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel.

Harel is a guest speaker for management and innovation courses at leading universities in the United States and Israel. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master’s in Business Administration (MBA) from Manchester University (UK).

Chen Levin

Chen Levin, CEO

Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen contributed to, and played an instrumental part of, the Israeli biomed industry’s continuous growth.

Prior to leading XACT, Chen served as the Executive Director of BioJerusalem, an initiative of the Prime Minister’s Office of the government of Israel to foster the biomed industry in Jerusalem, where she established numerous ventures and collaborations. Before BioJerusalem, Chen served as the CEO of Biomagnesium Systems Ltd., an early stage medical device company. Prior to this, Chen played a key role in the establishment of BioLineRx, Israel’s first Biomed Incubator (now a TASE publicly traded company).

Chen started her career in policy research, helping shape important government biomed industry support schemes. Chen is a member of the founding and steering committee of Women in the Life Sciences Organization (WLSO) in Israel.

Chen holds a BA degree in International Relations and an MBA in Finance, both from the Hebrew University of Jerusalem.

Shai Meltzer CFO

Shai Meltzer, CFO

Shai is a well-established executive with more than 20 years of management experience, which includes finance and accounting, developing business growth strategies, maximizing operating margins as well as building strong, diverse teams.

Prior to joining XACT, Shai was Head of Finance for Marvell Israel. Before this, Shai was the CFO at Wavion Networks. Most recently, Shai held a few key positions at Nanomotion, starting as CFO, VP Operations and then followed by a General Manager position. 

Shai holds a B.A. in Economics and Accounting from Haifa University, Israel.

Brian Allen

Brian Allen, VP Sales & Marketing

Brian brings to XACT Robotics over two decades of MedTech global sales and marketing experience leading multiple first-in-market transformative medical device technologies, building bespoke commercial teams, enrolling physician thought leaders and delivering value-based solutions through successful provider partnerships.

Recently, Brian served as Sr. Vice President of Business Development for HeartSciences (Southlake, TX), a disruptive cardiac diagnostic start-up where he was responsible for leading their global market release of the first wavelet signal processed electrocardiogram with AI machine learning.

Prior, he was Vice President of Sales and Commercial Marketing for OrthoSensor, Inc. (Dania Beach, FL) where he led their global strategy and commercial launch of the orthopedic industry’s first sensor-assisted instrument for total knee replacement surgery.

Before OrthoSensor, Brian led as Director of Sales and Marketing for MAKO Surgical Corp. (Davie, FL) where he was responsible for planning and executing the market launch and sustainable growth of the orthopedic industry’s first robotic-assisted surgery system. After scaling their annual revenues over $100M and through a successful IPO, MAKO Surgical subsequently exited through 13X acquisition to Stryker Inc. for $1.65B.

Early in his career, Brian held various progressive sales roles for several leading MedTech multinationals, such as Medtronic and Zimmer.  Brian holds a Bachelor of Arts (BA) from Western Michigan University and recently completed executive education in Artificial Intelligence: Implications for Business Strategy from the Sloan School of Management at the Massachusetts Institute of Technology.

Moran Shochat

Moran Shochat, SVP Strategic Innovations

Moran has over 15 years of software systems development and project leadership experience. Moran has extensive experience in medical device development, especially in the medical image-guided navigation space.

At his previous position, Moran led the software development activities at ActiViews (an early stage medical device venture, acquired by Stryker Corp. in 2013). Prior to this, Moran held a position at IBM’s research lab in Haifa where his focus was on developing tools and methods for software quality improvement.

Moran started his career at Odin Medical Technology (acquired by Medtronic in 2006) where he led the development of Odin’s MRI scanner navigation component.

Moran holds a B.Sc. in Computer Science, Technion from the Israel Institute of Technology. 

Tzuriel Keren_

Tzuriel Keren, VP Operations

Tzuriel brings 15 years of global operational leadership experience in the medical industry.

Prior to his role at XACT Robotics, Tzuriel served as VP Operations of Adin Group, a global leader in the design and manufacturing of dental implant solutions, where he led the company’s global operations strategy. 

Before Adin Group, Tzuriel served as a Director of Operations – Factory Manager at the Israel Defense Force (IDF), where he held several senior operations positions.

Tzuriel holds B-Tech degree in Electrical Engineering from Ort Braude College and an MBA in Business Administration from the College of Management Academic Studies (COMAS).

Dan Sigal

Dan Sigal, VP Quality Affairs & Regulatory Affairs

Dan is a seasoned Quality Affairs and Regulatory Affairs Manager with over 20 years of experience in the Medical Device industry. 

Dan gained diverse and extensive experience leading QA/RA in both smaller start-up companies, as well as in larger medical device corporations, both in Israel and in the USA. 

In previous positions, Dan developed and maintained comprehensive Quality Systems in compliance with the FDA’s QSR, European MDD, Chinese CFDA, and requirements of other Regulatory Authorities. He has overseen the registering of medical devices in different countries and regions worldwide and has worked with devices of different classes in the imaging, electrosurgical, and cardiovascular fields. 

Dan holds an M.Sc degree in Medicine Sciences and has completed numerous professional Quality and Regulatory courses.

Sagit Grinberg

Sagit Grinberg, VP Human Resources

Sagit has more than 15 years of experience managing all functional disciplines of human resources.

Prior to assuming her current role with XACT Robotics, she served as Director of Human Resources for Microbot Medical Inc., supporting the company during its transition to a public company. 

Prior to this, Sagit managed the human resources for the entire organization at Galil Medical. Before joining the medical arena, Sagit held a variety of human resources positions at Spiral Solutions.

Sagit has previous background in programming and computers and holds a Master’s degree in Human Resource Management (Cum laude) from the University of Derby, Bachelor of Arts in Sociology from Haifa University and is a certified moderator.

Danna-Perlman

Danna Perlman, Sr. Director of Intellectual Property

Danna brings over 12 years of experience in intellectual property management and strategy in the medical device field.

In addition to her position at XACT Robotics, Danna also serves as an IP consultant for MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures and Sheba Medical Center. She is currently also acting as the Director of IP Strategy & Development at Microbot Medical Inc. (Nasdaq: MBOT), an early stage company which develops a platform of micro-robots for various medical applications.

Before this, Danna was a leading member of the in-house IP team at Medingo Ltd., a medical device company which developed an insulin micro-pump for the treatment of diabetes and was acquired by Roche Diagnostics in 2010.

Until 2018, Danna served as a member of the Board of Directors at Prize4Life, a nonprofit organization dedicated to accelerating the discovery of treatment and cure for ALS. 

Danna holds an LL.B. in Law (magna cum laude) and a B.A. in Economics, both from the University of Haifa, and has a background in Biomedical Engineering from the Technion – Israel Institute of Technology. Danna is licensed to practice law in Israel.

BOARD OF DIRECTORS

Harel Gadot

Harel Gadot, Executive Chairman & President

Harel is a seasoned executive and entrepreneur in the healthcare space, with an extensive and proven track record. Harel brings over 19 years of experience in leadership positions in the corporate world as well as the start-up sector, including the United States, Europe, and Israel. Harel founded MEDX Ventures Group in 2010, a unique investment and management firm, and serves as its Company Group Chairman. 

Harel founded XACT Robotics in 2013 and serves as its Executive Chairman and President. He also serves as the CEO, President & Chairman of Microbot Medical Inc. (Nasdaq: MBOT), where he co-founded the company in 2011 and led it through its successful listing on NASDAQ in 2016. In addition, Harel is the founder and Chairman of MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures, and Sheba Medical Center. Until 2013, Harel served on the board of directors at ConTIPI Ltd., and played an instrumental role in its commercial efforts, resulting in its acquisition by Kimberly Clark Corporation. 

Until 2010, Harel served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville, NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, the Middle East, and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches (both from internal R&D and M&A). Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel.

Harel is a guest speaker for management and innovation courses at leading universities in the United States and Israel. Harel holds a Bachelor of Science (BS) from Siena College (USA) and a Master’s in Business Administration (MBA) from Manchester University (UK).

Chen Levin

Chen Levin, CEO & Director

Chen is a seasoned leader in the healthcare space with vast experience in management and operational positions. Throughout her career, Chen contributed to, and played an instrumental part of, the Israeli biomed industry’s continuous growth.

Prior to leading XACT, Chen served as the Executive Director of BioJerusalem, an initiative of the Prime Minister’s Office of the government of Israel to foster the biomed industry in Jerusalem, where she established numerous ventures and collaborations. Before BioJerusalem, Chen served as the CEO of Biomagnesium Systems Ltd., an early stage medical device company. Prior to this, Chen played a key role in the establishment of BioLineRx, Israel’s first Biomed Incubator (now a TASE publicly traded company).

Chen started her career in policy research, helping shape important government biomed industry support schemes. Chen is a member of the founding and steering committee of Women in the Life Sciences Organization (WLSO) in Israel.

Chen holds a BA degree in International Relations and an MBA in Finance, both from the Hebrew University of Jerusalem.

Sehldon D. Liber

Sheldon Liber, Director

Sheldon is an entrepreneur bringing over forty years of investing and leadership experience to XACT Robotics. He is the CEO and Chief Investment Officer of Chasing Value Asset Management, Inc. based in California. Over the past twenty years one of his primary investment focuses has been in the field of robotic medical devices. His initial foray into Intuitive Surgical in 2000, led to exponential returns and resulted in continued pursuit of companies with similar vision and quality management. He followed this up with investment in Mako Robotics (acquired by Stryker Corp. in 2013), Mazor Robotics (acquired by Medtronic in 2018), and most recently Corindus Vascular Robotics (acquired by Siemens in 2019). Chasing Value currently has significant holdings in multiple other companies in the medical robotic sector.

In addition to his specific knowledge of the medical technology sector, he is a California Licensed Architect, having worked with all levels of government and Fortune 100 companies on complex projects. Sheldon graduated from the University of Southern California in 1979 with a Bachelor of Architecture. He has written over 1,300 articles on investing and donates his time to local colleges and universities, educating the next generation on business and investment.

Yossi Bornstein

Yossi Bornstein, Director

Yossi is the founder and President of Shizim Group, one of Israel’s leading biomed service groups. Over the past 30 years Yossi has played key roles in the Israeli biomed industry.

Yossi was the General Manager of Bristol-Myers Squibb (Israel), until 1992. He subsequently founded Pharmateam Ltd., an Israeli company that successfully specialized in representing international pharmaceutical companies such as 3M Health Care, G.D. Searle, Shire, Medimmune, United Therapeutics, Forest Laboratories, Goldshield and others. Pharmateam was sold in 2000, when Yossi founded Shizim Ltd and through it, all its subsidiaries.

Yossi’s activity goes beyond the business world, also on a national level. He served as the Biotechnology Committee Chairman of USISTC (United States-Israel Science & Technology Commission), and also as a consultant for USISTF (United States-Israel Science & Technology Foundation). Through these organizations Yossi has initiated, founded and led a number of major national level projects for the Israeli life-science industry and for the State of Israel. Amongst these: ILSI (Israel Life Science Industry Organization) – the biggest organization in Israel for representing the mutual goals of the Israeli life science community, and ITTN (Israel Technology Transfer Organization), which serves as the umbrella organization for Israel’s academic Technology Transfer Offices, holding all innovative technologies from the entire Israeli academia.

Yossi is a Committee Member at The Life Science Forum of IPCC – the Israeli-Palestinian Chamber of Commerce, and has also served as a member of the Advisory Board – Life Science Industry, The Israel Export & International Cooperation Institute.

Yoav Waizer

Yoav Waizer, Director

Yoav has more than 20 years of entrepreneurial experience working with private and publicly traded technology companies. As a partner and CFO at leading Israeli VC funds that include recently Medica Venture Partners and previously, Cedar Fund and Star Ventures, he has worked with start-up companies from their very early stages all the way to successful exits. His hands-on experience includes all aspects of finance and operations including tax planning and reporting, cash management, reporting to limited partnerships under US GAAP rules, investor relations, and has expertise in strategy, financial and legal due diligence, general and financial management, team-building, monitoring portfolio companies, raising capital and M&A.

Yoav holds a B.Sc. in Statistics and Accounting and an MBA with a specialization in Information Systems, both from Tel Aviv University.

Simon Sharon

Simon Sharon, Director

Simon brings almost three decades of proven management and leadership experience in operations and research and development of medical devices.  

Currently, Simon serves as the Chief Technology Officer and Chairman of the Scientific Advisory board at Microbot Medical, an early stage company developing a platform of micro-robots for various medical applications.

Before Microbot, Simon was the Chief Technology Officer at MEDX Xelerator LP, a government supported medical devices incubator in Israel, with a partnership between MEDX Ventures Group, Boston Scientific Corporation, Intellectual Ventures and Sheba Medical Center. Previously Simon was the VP Research & Development at IceCure Medical Ltd., a TASE traded company developing a portfolio of cryogenic ablation systems. 

Before his experience with IceCure, Simon served as the CEO and VP Research & Development of Anorad Israel (a business unit of Rockwell Automation). Prior to Anorad, Simon was the Research & Development Manager at Disc-O-Tech Medical Technologies Ltd., a successful orthopedic venture (acquired by Kyphon, and currently part of Medtronic), and before this as the Research & Development Manager at CI Systems.

Simon holds a BSc. in Mechanical Engineering from the Technion – Israel Institute of Technology, a MSc. in Mechanical Engineering from MIT where he specialized in motion control and robotics, and an MBA from the Kellogg-Recanati School of Management.

MEDICAL ADVISORY BOARD

Dr Nahum Goldberg

Prof. Nahum Goldberg, MD

Prof. Nahum Goldberg is the Vice-Chairman for the Research Department of Radiology at Hadassah Hebrew University Medical Center, Jerusalem, Israel. His primary research interests focus upon uncovering methods to improve tumor ablation studies. As the Unit Head of Image-guided Therapy at Hadassah, he also has considerable experience with clinical trials and interventional oncologic techniques. 

Prof. Goldberg was named a Fulbright Scholar and Fellow of the Society of Interventional Radiology and served on multiple national and international committees advancing interventional oncology. ​ 

Prof. Goldberg’s external academic appointments and awards include Professor at Harvard University since 2007 and a Clinical and Research Fellowship in abdominal imaging and interventional radiology at Massachusetts General Hospital.

Dr Flacke

Prof. Sebastian Flacke, MD

Prof. Sebastian Flacke received his MD and PhD from the University of Bonn, Germany and his post-graduate fellowship training in Bonn, Germany and at Washington University St. Louis, US. He is trained and Board certified in diagnostic radiology, interventional radiology, neuroradiology including interventional neuroradiology. 

Prof. Flacke joined the Lahey Clinic in Boston in 2007 as Chief of Interventional Radiology and Director of non-invasive Cardiovascular Imaging and has since greatly expanded the interventional and cardiovascular program. Prof. Flacke is also Professor of Radiology at Tufts University Medical School.

Prof. Flacke’s main clinical focus is minimal invasive cancer treatment with a focus on liver treatment strategies. At Lahey Hospital and Medical Center, Prof. Flacke has introduced the radioembolization program, strategies for coil marking to support targeted surgery, various image guided treatment approaches and led more than 20 trials as Principal Investigator. He is a member of various professional societies, has contributed to various textbooks and authored more than 100 original papers.

Dr Eyal Morag

Dr. Eyal Morag, MD

Dr. Morag currently serves as Chairman of Radiology at Assuta Ashdod Medical Center, Ashdod Israel. 

Previously, Dr. Morag served as the Regional Radiology Director at Mercy Health Partners Hospitals in Toledo, Ohio. He was a senior member of University Radiology Group (one of the largest private Radiology groups in the U.S.).

Dr. Morag is a graduate of Boston University School of Medicine. He completed both his Radiology residency as well as Fellowship in Cardiovascular & Interventional Radiology at the Beth Israel Deaconess Medical Center & Harvard Medical School.

Following his clinical training, Dr. Morag joined a private practice in western Massachusetts where he served as Chief of Radiology at Holyoke Medical Center for several years.

Dr. Morag has extensive international experience developing and establishing radiology-related businesses. Those include teleradiology, Interventional Radiology services, and free-standing imaging centers.

Dr. Morag is certified by the American Board of Radiology and is currently involved as a consultant and co-founder in several Israeli startup companies ranging from AI to medical devices.